These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19355994)

  • 21. Protocol and preliminary results of a clinical study for comparison of solvent/detergent-inactivated plasma VIP versus FFP with special consideration of the balance of hemostasis.
    Beck KH; Mortelmans Y; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1994; 32():440-4. PubMed ID: 9422123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction of coagulation in dilutional coagulopathy: use of kinetic and capacitive coagulation assays to improve hemostasis.
    Schols SE; Heemskerk JW; van Pampus EC
    Transfus Med Rev; 2010 Jan; 24(1):44-52. PubMed ID: 19962574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults.
    Park YA; Waldrum MR; Marques MB
    Am J Clin Pathol; 2010 Mar; 133(3):460-5. PubMed ID: 20154285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of acquired coagulation disorders in emergency and intensive-care medicine.
    Staudinger T; Locker GJ; Frass M
    Semin Thromb Hemost; 1996; 22(1):93-104. PubMed ID: 8711494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant.
    O'Shaughnessy DF; Atterbury C; Bolton Maggs P; Murphy M; Thomas D; Yates S; Williamson LM;
    Br J Haematol; 2004 Jul; 126(1):11-28. PubMed ID: 15198728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications for plasma in massive transfusion.
    Hellstern P; Haubelt H
    Thromb Res; 2002 Oct; 107 Suppl 1():S19-22. PubMed ID: 12379288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of trauma-induced coagulopathy - what is the evidence?].
    Guth MC; Kaufner L; Kleber C; von Heymann C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Sep; 47(9):528-39; quiz 540. PubMed ID: 22968981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solvent/detergent-treated plasma: composition, efficacy, and safety.
    Hellstern P
    Curr Opin Hematol; 2004 Sep; 11(5):346-50. PubMed ID: 15666659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic plasma exchange and plasma infusion in thrombotic microvascular syndromes.
    Barz D; Budde U; Hellstern P
    Thromb Res; 2002 Oct; 107 Suppl 1():S23-7. PubMed ID: 12379289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura.
    de la Rubia J; Arriaga F; Linares D; Larrea L; Carpio N; Marty ML; Sanz MA
    Br J Haematol; 2001 Sep; 114(3):721-3. PubMed ID: 11553005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO; MacLaren R
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fresh plasma and concentrates of clotting factors for therapy of perioperative coagulopathy: what is known?].
    Heindl B; Spannagl M
    Anaesthesist; 2006 Sep; 55(9):926, 928-36. PubMed ID: 16721605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review.
    Ramsey G
    Best Pract Res Clin Haematol; 2006; 19(1):113-26. PubMed ID: 16377545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases.
    Mueller MM; Bomke B; Seifried E
    Thromb Res; 2002 Oct; 107 Suppl 1():S9-17. PubMed ID: 12379287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
    Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired Bleeding Disorders.
    Hurwitz A; Massone R; Lopez BL
    Hematol Oncol Clin North Am; 2017 Dec; 31(6):1123-1145. PubMed ID: 29078927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy.
    Hellstern P; Haubelt H
    Thromb Res; 2002 Oct; 107 Suppl 1():S3-8. PubMed ID: 12379286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.